On "Bad" Profits

Ranting on regulations that will end up restricting biotech at the expense of big pharma in the new healthcare bill (the Atlantic):

Profits are good when they result from providing a service people want. When they are the result of capturing the government by cutting special deals, they're immoral and inefficient. And this is just the beginning . . .

This at least explains big pharma's support of the recent US healthcare bill.